Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Chlorpropamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | THRB | P10828 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | HTR2A | P28223 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 1.00 |
| ▸ | CA12 | O43570 | 1/20 | 0.63 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | CA9 | Q16790 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | ALB | P02768 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | FBP1 | P09467 | 7/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chlorpropamide SCHEMBL1537108 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Chlorpropamide SCHEMBL28353575 | 0.98 | ALDH1A1 (0.97) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Chlorpropamide SCHEMBL6471158 | 0.97 | ALDH1A1 (0.94) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Chlorpropamide SCHEMBL6471167 | 0.92 | ALDH1A1 (0.84) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Chlorpropamide SCHEMBL6471173 | 0.92 | ALDH1A1 (0.84) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Chlorpropamide SCHEMBL20770748 | 0.91 | ALDH1A1 (0.82) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Tolbutamide SCHEMBL12498646 | 0.89 | ALDH1A1 (0.82) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Chlorpropamide SCHEMBL20771094 | 0.88 | ALDH1A1 (0.78) | ALDH1A1LMNATSHRCYP3A4THRB | |
| Carbutamide SCHEMBL7615910 | 0.88 | ALDH1A1 (0.78) | ALDH1A1LMNATSHRCYP3A4THRB | |
| SCHEMBL19361072 | 0.87 | ALDH1A1 (0.77) | ALDH1A1LMNATSHRCYP3A4THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 38998 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026104273-A1 | COSMETIC COMPOSITION COMPRISING A CATIONIC INULIN, A GLUCAMIDE AND AN ANIONIC SURFACTANT, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2026-05-21 | — | — | WO | claimed |
| EP-4743051-A1 | 3-HYDROXYPROPYLESTERS AS SOLUBILITY ENHANCERS FOR LIPOPHILIC INGREDIENTS | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| EP-4525816-B1 | WAX DISPERSIONS | BASF SE (DE) | 2026-05-20 | — | — | EP | claimed |
| CN-122011282-A | Polyacrylamide based on molecular chain topological structure regulation and synthesis method thereof | 黑龙江吉地油田服务股份有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260124282-A1 | DECORIN FOR ITS USE IN THE TREATMENT OF DIABETES | CENTRE EUROPEEN D'ETUDE DU DIABETE (FR) | 2026-05-07 | — | — | US | claimed |
| US-20260115210-A1 | METHOD FOR TREATING SUBJECTS SUFFERING FROM CENTRAL NERVOUS SYSTEM CONTUSIONS | REMEDY PHARMACEUTICALS, INC. (US) | 2026-04-30 | — | — | US | claimed |
| US-12611416-B2 | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema | REMEDY PHARMACEUTICALS, INC. (US) | 2026-04-28 | — | — | US | claimed |
| US-20260109915-A1 | SILICONE AND SULFATE-FREE CONDITIONING SHAMPOO | L'OREAL (FR) | 2026-04-23 | — | — | US | claimed |
| EP-4717267-A1 | SYNERGISTIC COMBINATION FOR TREATING CANCER | FUNDACION UNIVERSITARIA SAN ANTONIO (UCAM) (ES) | 2026-04-01 | — | — | EP | claimed |
| US-4474752-A | DIAMINE MODIFIED POLYOXYETHYLENE-POLYOXYPROPYLENE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| EP-0091193-A2 | Antidiabetic compositions | PFIZER INC. (US) | 1983-10-12 | — | — | EP | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4254109-A | INHIBIT LENS ALDOSE REDUCTASE | AYERST, MCKENNA & HARRISON INC. (CA) | 1981-03-03 | — | — | US | claimed |
| US-4254108-A | ALDOSE REDUCTASE INHIBITORS | AYERST, MCKENNA & HARRISON INC. (CA) | 1981-03-03 | — | — | US | claimed |
| US-4062889-A | Preparation of sulfonylureas | ERIC LUCIEN | 1977-12-13 | — | — | US | claimed |
| US-4036227-A | Osmotic releasing device having a plurality of release rate patterns | ALZA CORPORATION (US) | 1977-07-19 | — | — | US | claimed |
| US-4014334-A | Laminated osmotic system for dispensing beneficial agent | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |
| US-4008719-A | Osmotic system having laminar arrangement for programming delivery of active agent | ALZA CORPORATION (US) | 1977-02-22 | — | — | US | claimed |
| US-3977404-A | OSMOTIC DEVICE HAVING MICROPOROUS RESERVOIR | ALZA CORPORATION (US) | 1976-08-31 | — | — | US | claimed |